ArticleJournal of translational research2026

CRISPR/Cas9 gene editing in hematopoietic stem and progenitor cells to accelerate the translation of cellular therapies and immunotherapies.

Laura Falceto Font et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.